Clinical evaluation of a new alkylating agent, azetepa, in one hundred and twenty-five cases of malignant tumors.
D000477:Alkylating Agents / Q000627:therapeutic use*; D001388:Aziridines / Q000627:therapeutic use; D001389:Azirines / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010721:Phosphinic Acids / Q000627:therapeutic use*
D000477:Alkylating Agents; D001388:Aziridines; D001389:Azirines; D010721:Phosphinic Acids